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Shiga toxin-producing Escherichia coli (STEC) are an emerging group of zoonotic
pathogens. Ruminants are the natural reservoir of STEC. In this study we determined
the prevalence and characteristics of the STEC in plateau pika (Ochotona curzoniae)
on the Qinghai-Tibetan Plateau, China. A total of 1116 pika samples, including 294
intestinal contents samples, 317 fecal samples, and 505 intestinal contents samples,
were collected from May to August in the years 2012, 2013, and 2015, respectively.
Twenty-one samples (1.88%) yielded at least one STEC isolate; in total, 22 STEC isolates
were recovered. Thirteen different O serogroups and 14 serotypes were identified. One
stx1 subtype (stx1a) and three stx2 subtypes (stx2a, stx2b, and stx2d) were present in the
STEC isolates. Fifteen, fourteen, and three STEC isolates harbored the virulence genes
ehxA, subA, and astA, respectively. Adherence-associated genes iha and saa were,
respectively, present in 72.73 and 68.18% of the STEC isolates. Twenty antibiotics were
active against all the STEC isolates; all strains were resistant to penicillin G, and some to
cephalothin or streptomycin. The 22 STEC isolates were divided into 16 pulsed-field gel
electrophoresis patterns and 12 sequence types. Plateau pikas may play a role in the
ongoing circulation of STEC in the Qinghai-Tibetan plateau. This study provides the first
report on STEC in plateau pikas and new information about STEC reservoirs in wildlife.
Based on the serotypes, virulence gene profiles and multi-locus sequence typing (MLST)
analysis, the majority of these pika STECs may pose a low public health risk.
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INTRODUCTION
Shiga toxin-producing Escherichia coli (STEC) represents an emerging group of zoonotic
pathogens causing diarrhea, hemorrhagic colitis (HC), and the life-threatening hemolytic uremic
syndrome (HUS) in humans (Smith et al., 2014). Strains of O157 serogroup have been considered
to be most virulent, and STEC O157 strains have been extensively studied and shown to be involved
in many cases and outbreaks of human disease (Doorduyn et al., 2006; Friesema et al., 2007;
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Sigmundsdottir et al., 2007; Greenland et al., 2009). However,
there is growing concern over the emergence of more than
200 non-O157 STEC serotypes associated with human illness,
including the life threatening HUS (Coombes et al., 2008).
In fact, non-O157 strains are responsible for a larger portion
of STEC infections than O157 strains in the United States,
Canada, Australia, Latin America, and Europe (Karmali et al.,
1985; Caprioli et al., 1997; Tozzi et al., 2003; Brooks et al.,
2005). At present, detection methods and in depth studies are
mainly focused on O157:H7 and the top six serogroups of STEC
(O26, O45, O103, O111, O121, and O145) (Conrad et al., 2014;
Wasilenko et al., 2014), thus the public health significance of
STEC of other serotypes is likely to be underestimated due to the
high diversity of genotypes and phenotypes.
Shiga toxin (Stx) is the most critical virulence factor
of STEC, consisting of two broad immunologically different
types: Stx1 with three subtypes (Stx1a, Stx1c, and Stx1d) and
Stx2 with seven subtypes (Stx2a to Stx2g). Stx can damage
intestinal epithelial cells and kidneys, causing HC and HUS
(Smith et al., 2014). However, many non-O157 strains that
produce Shiga toxin have been not associated with HUS cases,
indicating additional virulence determinants may play a role
in pathogenesis. Following initial attachment of STEC to host
intestinal cells, strains that express intimin can intimately
attach to host cells and cause the attaching-and-effacing lesion
(Frankel and Phillips, 2008). Intimin is encoded by eae that
resides on a chromosomal pathogenicity island called the
locus of enterocyte effacement (LEE). Enterohemolysin (EhxA),
encoded by a 60-MDa virulence plasmid in some STEC strains,
that readily causes hemolysis of washed sheep erythrocytes,
is another important virulence factor that contributes to
severe disease in humans (Cookson et al., 2007). A number
of other adherence structures and virulence factors have
also been proposed to contribute to STEC pathogenesis
(Coombes et al., 2008; Tseng et al., 2014; Chui et al.,
2015).
Though the main reservoir of STEC is the intestinal tract
of cattle, many other domestic and wild animals including
pig, sheep, dog, deer, wild boar, and hare are also sources of
STEC (Oporto et al., 2008; Miko et al., 2009; Sanchez et al.,
2010; Bentancor et al., 2012; Shen et al., 2015). STEC strains
have been described recently in diarrheal patients, domestic
animals and foodstuffs of animal origin in China (Xiong et al.,
2012; Chen et al., 2014; Meng et al., 2014; Bai et al., 2015;
Wang et al., 2015; Yu et al., 2015), but little data is available
concerning wildlife. The plateau pikas (Ochotona curzoniae) are
underground-dwelling mammals (order Lagomorpha) mostly
living in the extremely harsh wild environments of severe cold,
low atmospheric oxygen and strong ultraviolet radiation of the
Qinghai-Tibetan plateau, China. Plateau pikas have close contact
with yaks. In our previous study, we explored the occurrence
and characteristics of STEC in yaks (Bos grunniens) for the
first time, revealing that yaks are natural reservoirs of STEC,
and some of the STEC strains they harbored had the potential
to cause human disease (Bai et al., 2013). In this study, we
investigated the prevalence of STEC in plateau pikas in this
unique ecosystem.
MATERIALS AND METHODS
Collection of Samples
Four sites were enrolled in this study in Yushu tibetan
autonomous prefecture, Qinghai province, China, including
Guoqinggou [3,929 m above msl (mean sea level), latitude of
33◦7′ and longitude of 96◦84′), Jielachong (3,970 m above msl,
latitude of 33◦48′ and longitude of 96◦51′), Gandacun (4,322 m
above msl, latitude of 33◦13′ and longitude of 96◦73′), Batangtan
(3,987 m above msl, latitude of 32◦51′ and longitude of 96◦56′)].
The plateau pikas were captured by ‘mousetrap’ in their breeding
seasons from May to August when their population densities
are high, and the colon contents were collected. Fresh feces
were picked up from the holes. In total, 1116 samples were
collected consisting of 294 colon contents samples, 317 fecal
samples, and 505 colon contents samples in the years 2012, 2013,
and 2015, respectively. Samples were mixed in Luria-Bertani
medium containing 30% glycerol (Land Bridge, Beijing, China),
stored at −20◦C immediately, and transported to the laboratory
in National Institute for Communicable Disease Control and
Prevention, China CDC, in ice cold conditions for the screening
of STEC.
Isolation of STEC
One gram of each sample was enriched into 5 ml of E. coli
broth (Land Bridge, Beijing, China) and incubated at 37◦C for
18 to 24 h with shaking at 200 rpm. The enriched samples were
investigated for stx1 and stx2 genes by duplex PCR assay as used
in our previous study (Bai et al., 2015). Briefly, 1.5 ml of each
enrichment sample was centrifuged at 13,000 × g for 2 min, the
pellet was suspended in 150 µl of lysis buffer (100 mM NaCl,
10 mM Tris-HCl [pH 8.3], 1 mM EDTA [pH 9.0], 1% Triton
X-100), then boiled for 10 min, and centrifuged at 13,000 × g
for 2 min. The supernatant was then used as the PCR template.
Enriched samples that tested positive for stx1 and/or stx2 genes
were plated onto CHROMagarTM ECC agar (CHROMagar, Paris,
France), and MacConkey agar (Oxoid, Hampshire, UK) and then
incubated at 37◦C overnight. About 10 colonies (blue or colorless,
round moist E. coli-like colonies) on CHROMagarTM ECC and 5
pink or red colonies on MacConkey were picked to screened for
the presence of stx1 and/or stx2 genes by single colony duplex
PCR assay (Bai et al., 2015). If all colonies were negative for
stx, another 10 and 5 colonies on the two plates were picked
and screened. Finally, with the exception of different colony
colors (blue or colorless), stx types or stx combinations present
in the same sample, only one STEC isolate from each stx-positive
sample was kept for further identification as described previously
(Bai et al., 2015).
Biochemical Tests and Serotyping of
STEC Isolates
Each stx-positive isolate was confirmed to be E. coli by
biochemical identification using the API 20E system
(bioMérieux, Marcy l’Etoile, France). The O serogroup was
determined using all available E. coli antisera, i.e., O1–O188
(Statens Serum Institut, Hillerød, Denmark). The entire coding
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sequence of fliC was amplified by PCR using primers F-FLIC1
(5′-ATGGCACAAGTCATTAATACCCAAC-3′) and R-FLIC2
(5′-CTAACCCTGCAGCAGAGACA-3′), as reported by Fields
et al. (1997), then sequenced and compared to a publicly available
CGE SerotypeFinder web tool1 to determine the H type of each
isolate (Joensen et al., 2015).
stx Subtyping
The stx1 subtypes of STEC isolates were determined by a PCR-
based subtyping method devised by Scheutz et al. (2012). The
complete stx2 gene was amplified as described by Gunzer et al.
(1992), then cloned into vector pMD18-T and transformed into
E. coli JM109 (Takara, Dalian, China). About 10 transformants
were selected for sequencing to discern multiple stx2 subtypes in
a PCR product. A neighbor-joining tree was constructed using
MEGA 6 (Tamura et al., 2013) to assign the stx2 subtype (Scheutz
et al., 2012).
All stx2 nucleotide sequences determined in this study
have been submitted to GenBank under accession numbers
KU158844-KU158861.
Detection of Virulence and Adherence
Factors
Shiga toxin-producing Escherichia coli isolates were subjected
to PCR for detection of intimin-encoding gene (eae), putative
adhesin genes (iha, efa1, saa, paa, eibG), virulence-associated
genes (ehxA, katP, toxB, astA, subA), the high-pathogenicity
island (HPI) marker genes (irp2 and fyuA) and 11 non-LEE
encoded effector (nle) genes (ent, nleA, nleB, nleB2, nleE,
nleH1-1, nleH1-2, nleC, nleD, nleF, nleG ) using primers listed in
Supplementary Table S1.
Antimicrobial Susceptibility Testing
Antimicrobial drug susceptibility was determined by the
disk diffusion method as recommended by the Clinical and
Laboratory Standards Institute (Clinical Laboratory Standards
Institute [CLSI], 2014). We tested the following 23 antimicrobial
agents: penicillin G, amoxicillin/clavulanic acid, ampicillin/
sulbactam, levofloxacin, nitrofurantoin, aztreonam, norfloxacin,
chloramphenicol, cefepime, cephalothin, meropenem, ceftria-
xone, imipenem, streptomycin, ciprofloxacin, gentamicin,
piperacillin, cefotaxime, nalidixic acid, kanamycin,
trimethoprim-sulfamethoxazole, cefuroxime, and tetracycline
(Oxoid, Hampshire, UK). Results were used to classify isolates
as being resistant or susceptible to a particular antibiotic
using standard reference values (Clinical Laboratory Standards
Institute [CLSI], 2014).
Pulsed-Field Gel Electrophoresis (PFGE)
Shiga toxin-producing Escherichia coli isolates were digested with
XbaI and separated by pulsed-field gel electrophoresis (PFGE)
according to the protocol for non-O157 STEC from PulseNet,
USA2. Gel images were captured with a Gel DocTM XR+
1http://cge.cbs.dtu.dk/services/
2http://www.cdc.gov/pulsenet/pathogens/index.html
system (Bio-Rad, Hercules, CA, USA). An UPGMA (unweighted
pair-group method with arithmetic mean) dendrogram was
constructed using BioNumerics software version 4.0 (Applied
Maths, Sint-Martens-Latem, Belgium).
Multi-locus Sequence Typing (MLST)
All STEC isolates were analyzed by multi-locus sequence typing
(MLST) according to the E. coli MLST website3. Sequences types
(STs) of the HUSEC (HUS-associated enterohemorrhagic E. coli)
collection were obtained from http://campus.uni-muenster.
de/hyg_klhus_husec.html?&L = 1 (Mellmann et al., 2008). All
human STEC STs of O157 and the top six serogroups were
obtained from the E. coli MLST website. A minimum spanning
tree based on these STs was generated using BioNumerics
software.
Statistical Analysis
The χ2 test was performed using SAS software version 9.1
(SAS Institute Inc., Cary, NC, USA). P < 0.05 was considered
statistically significant.
Ethics Statement
The pikas in this study were captured by ‘mousetrap’ by local
center for disease control and prevention for communicable
diseases surveillance. The study was approved by the ethics
committee of National Institute for Communicable Disease
Control and Prevention, China CDC, according to the medical
research regulations of National Health and Family Planning
Commission of the People’s Republic of China.
RESULTS
Prevalence of STEC in Plateau Pika
Samples
Twenty-two STEC isolates were obtained from 21 of the 58
stx-positive plateau pika samples giving a culture positive rate
of 36.21% for stx-positive samples and 1.88% for all samples
(Table 1). Single isolate was obtained from 19 intestinal content
samples and one fecal sample. Two isolates (15ST443 and
15ST444) with different stx types were recovered from one
intestinal contents sample collected in 2015. Nine out of 294
intestinal contents samples collected in 2012, one out of 317 fecal
samples collected in 2013, and 11 out of 505 intestinal contents
samples yielded STEC isolates, giving culture positive rates of
3.06, 0.32, and 2.18% for all samples, respectively (Table 1). The
culture positive rates in intestinal contents were much higher
than that in feces (P < 0.05).
Serogroups and Serotypes
In total, 13 different O serogroups and 7 different H types
were identified among the 22 STEC isolates, which belonged
to 14 serotypes: O2:H45, O8:H2, O8:H16, O49:H21, O74:H8,
O81:H21, O82:H19, O96:H8, O119:H19, O120:H9, O159:H21,
3http://mlst.warwick.ac.uk/mlst/dbs/Ecoli
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O163:H19, O169:H8, and O170:H8. The predominant serotypes
were O8:H2, O2:H45, O74:H8, and O49:H21 of which we found
four (18.18%), three (13.64%), three (13.64%) and two (9.09%)
isolates, respectively. The remaining 10 serotypes were each
represented by only one isolate (Figure 1).
Presence of stx Genes and stx Subtypes
and Other Virulence Factor Genes
Among the 22 STEC isolates, five tested positive for stx1 only,
14 for stx2 only, and three for both stx1 and stx2. All of the
eight stx1 were subtyped into stx1a. Of the 17 stx2-positive
STEC isolates, one was subtyped into stx2a, five were stx2b,
10 were stx2d, and one isolate carried both stx2a and stx2d
(Figure 1).
All 22 STEC isolates were eae negative. Of the five other
putative adhesin genes (iha, saa, efa1, paa, eibG) screened,
iha and saa were present in 16 (72.73%) and 15 (68.18%)
isolates, respectively, and the 15 saa positive STEC isolates also
carried iha. The other three adhesin genes were not detected
in any of the 22 isolates. We also screened five virulence-
associated genes (ehxA, katP, toxB, astA, subA), two markers
for HPI (irp2 and fyuA), and 11 non-LEE encoded effector
(nle) genes. Fifteen (68.18%) STEC isolates were positive for
ehxA, fourteen (63.64%) and three (13.64%) were positive
for subA and astA, respectively. All our STEC isolates were
TABLE 1 | Prevalence of Shiga toxin-producing Escherichia coli in plateau pika.
Year Type of sample Number of
samples
Number of stx
positive (%)
Number of samples with
STEC isolates (%)
Number of STEC
isolates (%)
2012 Intestine contents 294 10 (3.40) 9 (3.06) 9 (3.06)
2013 Feces 317 2 (0.63) 1 (0.32) 1 (0.32)
2015 Intestine contents 505 46 (9.11) 11 (2.18) 12 (2.38)
Total 1116 58 (5.20) 21 (1.88) 22 (1.99)
FIGURE 1 | Pulsed-field gel electrophoresis (PFGE) profiles of 22 non-O157 Shiga toxin-producing Escherichia coli (STEC) isolates from plateau
pikas. The corresponding isolate names, PFGE patterns, sequence types (STs), serotypes, stx1 and stx2 subtypes, the profiles of ehxA, iha, saa, subA, and astA
genes, and antibiotic resistances are listed on the right. Year of sampling is contained in the first two numbers of the isolate names: 12 means year 2012, 13 means
2013, and 15 means 2015. Abbreviations for antibiotics are: S, Streptomycin; KF, Cephalothin. ‘+’ means genes positive or antibiotic resistant; ‘−’ means genes
negative or antibiotic susceptible.
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negative for katP, toxB, the HPI genes and the 11 nle genes
(Figure 1).
Antibiotic Resistance
Antimicrobial resistance was determined using 23 antibiotics.
All 22 STEC isolates were resistant to penicillin G. Four and
one isolates were resistant to cephalothin and streptomycin,
respectively, giving resistance rates of 18.18 and 4.55%. All
isolates were susceptible to the remaining 20 antibiotics
(Figure 1).
Pulsed-Field Gel Electrophoresis (PFGE)
The 22 non-O157 STEC isolates were analyzed by PFGE to
investigate their genetic relationships. All isolates produced
clear bands, and could be divided into 16 PFGE patterns
(EMSX11001 to EMSX11016). An UPGMA dendrogram showed
that the STEC isolates were genetically diverse with nodes
linking isolates at less than 90% similarity (Figure 1). Four
isolates (12ST452, 12ST453, 12ST454, 12ST459) from intestinal
contents collected in 2012, two isolates (15ST441, 15ST444)
from intestinal contents collected in 2015, and three isolates
(12ST456, 15ST442, and 15ST447) from intestinal contents
collected in different years (two in 2015 and one in 2012)
showed identical PFGE patterns, sequence type, serotype and
virulence gene profile. The two isolates (15ST443, 15ST444)
obtained from a single intestinal contents sample showed
different PFGE patterns, serotypes and virulence gene profiles
(Figure 1).
Multi-locus Sequence Typing (MLST)
A total of 12 different sequence types (STs) were identified
among the 22 STEC isolates, including one novel sequence
type, ST5741, resulting from a novel allele type, icd 592.
ST1001 was the most frequent ST, represented by four
isolates with identical PFGE pattern, serotype, virulence gene
profile and antibiotic resistance pattern. Three STs (ST297,
ST906, and ST3692) were represented by three isolates each.
Among these, the ST297 isolates showed different PFGE
patterns, serotypes and stx profiles; ST906 isolates demonstrated
different PFGE patterns and stx profiles; while ST3692 isolates
exhibited an identical PFGE pattern, serotype, virulence gene
profile and antibiotic resistance pattern. ST40 was detected
in two isolates with different resistance patterns, and the
other seven STs were found only once. There is a good
concordance between MLST and PFGE; isolates of the same
ST generally showed the same or similar PFGE patterns
(Figure 1).
DISCUSSION
The Qinghai-Tibetan plateau is a region where the altitude
is high, the temperature is low and ultraviolet radiation is
strong. Plateau pikas (O. curzoniae) play important roles in
this ecosystem, such as recycling nutrients in soil, providing
food to predators, and providing microhabitats by increasing
plant richness, while their burrows provide nests for small
birds and reptiles (Yu et al., 2012). Plateau pikas have been
proved to be a reservoir of some pathogens (Zhang et al.,
2013; Yu et al., 2014). In the current research, we found that
5.2% (58/1116) of the plateau pika samples were positive for
the stx genes by PCR and 1.88% (21/1116) by microbiological
culture. The prevalence of STEC in plateau pikas is much
lower than that in yaks from the same geographical region (Bai
et al., 2013), where 11.68% (85/728) of samples yielded STEC
strains. Notably, more than 60% of the stx-positive samples by
PCR were negative by culture in this study. It was inferred
that several factors may result in the failure to isolate STEC
from the stx-positive samples, such as the low levels of STEC
in the samples, the perturbation of high levels of background
microflora, the presence of other bacteria carrying stx, the
interference of free Stx phages (Quiros et al., 2015). Different
STEC isolation methods may also contribute to the recovery
of different serotype strains (Kalchayanand et al., 2013) and
dual plating on lesser and more highly selective agars may
maximize the recovery of target STEC strains (Gill et al., 2014).
A possible reason for no isolation of STEC O157 and the top
six non-O157 STEC strains might be the method used. In this
study, we used CHROMagarTM ECC and MacConkey agars
and didn’t specifically target O157 or the top six serogroups.
For instance, use of O157 or the top six serogruops specific
immunomagnetic beads to capture the bacteria from enrichment
broth with subsequent culture in selective media are required
in further study to improve the isolation of these strains.
Notably, STEC were similarly distributed in intestine content
samples collected in the years 2012 and 2015, while the
prevalence in feces was much lower, according with observations
on swine STEC strains in our previous study (Meng et al.,
2014).
The STEC isolates from plateau pikas were highly genetically
diverse, revealed by serotyping, PFGE, MLST, and virulence
gene profiles. Isolates from different samples collected in
the same or different years (four isolates from year 2012,
two isolates from 2015, and three isolates from 2012 and
2015) had an identical PFGE pattern, sequence type, serotype
and virulence gene profile, implying some STEC clones
may be widespread and persistent in this region. STEC
isolates 15ST443 and 15ST444 obtained from the same
intestinal contents sample showed different PFGE patterns,
serotypes and virulence gene profiles, indicating that some
plateau pikas could be colonized by more than one STEC
clone.
The predominant serotypes O8:H2 and O2:H45 were also
observed in yak STEC isolates, and O2:H45 was the most
common serotype among yak isolates (Bai et al., 2013). Nine
sequence types (ST40, ST297, ST737, ST906, ST1001, ST3686,
ST3692, ST3883, and ST3884) were identified in STEC from
both yaks (Sun et al., 2013) and plateau pikas, suggesting some
STEC strains may be widely spread among animals in the same
geographical region; however, the transmission route remains
to be understood. Resistance to multiple antimicrobials has
been shown in many non-O157 STEC isolates from humans,
animals and food (Stephan and Schumacher, 2001). Wong
et al. (2000) supported the theory that antibiotics play an
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important role in the progression of HUS and therefore the
resistances of STEC may have relevance to clinical symptoms.
In the present study, 20 of the 23 antimicrobial agents were
active against all 22 plateau pika STEC isolates, the exceptions
being penicillin G, cephalothin and streptomycin. These results
were quite different from those observed in healthy pigs
in China, where only two of the 23 antimicrobial agents
(imipenem and meropenem) were active against all the STEC
isolates (Meng et al., 2014). The lower antibiotic resistance
may due to a low prevalence of drug resistant bacteria in this
ecosystem.
Shiga toxin (Stx) production, especially Stx1a, Stx2a, Stx2c,
and Stx2d, has been implicated in causing severe disease and
HUS, and STEC carrying Stx2b are mainly associated with
diarrheal disease (Friedrich et al., 2002; Jelacic et al., 2003;
Bielaszewska et al., 2006). Adherence to the intestinal epithelium
and subsequent colonization are crucial for the STEC pathogenic
process. STEC isolates that carry both stx2 and eae genes are often
associated with severe disease (Werber et al., 2003). Coombes
et al. (2008) reported that non-LEE encoded effector (nle) genes
are correlated with outbreak and HUS potential in humans.
In the present study, different profiles, i.e., stx1a, stx2a, stx2b,
stx2d, stx1a + stx2d, and stx2a + stx2d, were present in the
22 non-O157 STEC isolates, but all were eae negative. Some
of the isolates carried virulence genes ehxA (68.18%), subA
(63.64%), astA (13.64%), or adherence genes iha (72.23%) and
saa (68.18%). Other novel virulence or adherence factors in
these STEC isolates besides stx need to be further investigated.
Multi-locus sequence typing identified 12 STs obtained in this
study. The 32 STs of the HUSEC collection and 36 human
STEC STs from the E. coli MLST database were considered
to assess the potential risk of human infection by plateau
pika STEC strains. None of the STs of plateau pika STEC
were identical to any of the human STEC STs. Only one,
ST40, with two isolates (15ST441 and 15ST444), was also
observed in the HUSEC collection (Figure 2), but these two
isolates harbored the low-virulence stx2b gene and no other
virulence genes were detected. These data suggest that STEC
in plateau pikas may have low potential to cause human
disease.
In China, STEC O157 strains were detected in different
animals and caused a major outbreak in 1999 (Xiong et al., 2012;
Meng et al., 2013). Non-O157 STEC strains have been isolated
from different animals and raw meats in China as reported in
FIGURE 2 | Minimum spanning tree of 12 STs from this study (blue), 32 STs from the HUSEC collection (red), and 36 STs from human STEC STs of
serogroups O26, O45, O103, O111, O121, O145, and O157 in the E. coli MLST database (green). Each circle represents a ST, with the pie divided
proportionally to the number of isolates in that ST from different sources. The number in a circle indicates the ST number. The numbers on connecting lines represent
the number of allelic differences between two STs.
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our previous studies (Bai et al., 2013, 2015; Meng et al., 2014).
In recent years, STEC isolates including O157 and non-O157
serogroups have been reported in diarrheal patient by several
other studies in China (Chen et al., 2014; Wang et al., 2015; Yu
et al., 2015), but limited information is available regarding the
phenotypic and genetic characteristics of these STEC isolates.
Thus, further indepth studies on STECs from different resources
in China are required to determine their pathogenic potential.
CONCLUSION
We initially revealed that plateau pikas may be a natural
reservoir of STEC, extending our knowledge of the genetic
diversity and reservoir host range of STEC. Based on comparison
by serotypes and MLST analysis with human strains and
presence of virulence genes, the majority of these pika STECs
may have a low potential to cause human disease. However,
further investigations are needed to assess the public health
significance in Tibetans and nomadic pastoralists in this
geographic region.
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